National Diabetes Audit - 2011-12

The National Diabetes Audit identified an issue with data supplied to the HSCIC for the 2011-12 Audit, regarding HbA1c (blood glucose) recording across a number of practices. While this did not materially affect the findings in the National report, in November 2014 we removed the CCG level care process and treatment target reports covering potentially affected practices.  The 2011-2012 Data has been re-published in the 2012-2013 CCG reports with the following Data Quality note;

There has been an issue identified with data supplied to the HSCIC for the 2011-12 Audit, regarding HbA1c (blood glucose) recording across a number of practices in this CCG.  This does not materially affect the findings in the National report.  Caution should be taken when comparing data, for HbA1c and all eight care processes.

The issue does not affect the 2012-2013 data and is restricted only to the 2011-2012 data presented in Table 3, Figure 3, Figure 4, and Figure 5 in the CCG level reports for those affected.
 

We are working with our suppliers to resolve this issue and will update this page as soon as possible.

2011-2012 National Diabetes Audit (NDA) report. Report 1 shows Care Processes and Treatment targets.

This national report from the ninth year of the audit presents key findings on key care processes and treatment target achievement rates from 2011-2012 in all age groups in England and Wales. The care processes and treatment target standards are specified in NICE Clinical Guidelines and the NICE Diabetes in Adults Quality Standards. The NDA also reports on the complications of diabetes, mortality and other complications. These will be published in report 2 towards the end of the year.

Due to the size of this publication, the data have been organised alphabetically by CCG profile and split into several pages, which are linked to below.

On 9th April 2014 a National Diabetes Audit (NDA) Report 2011-12 summary report was added to this release. This presents the NDA care processes, treatment targets, complications and mortality data in a more accessible patient friendly format.